Invesaro

Stocks Health care COSM

NASDAQ · Health care

Cosmos Health Inc. (COSM)

Cosmos Health Inc. brought in $73.7M of revenue over the twelve months to June 30, 2026, up 33.8% from a year earlier. It posted a net loss of $24.4M. In fiscal 2025 capital spending exceeded operating cash flow by $8.5M. At June 30, 2026 it held $1.8M in cash against $3.2M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 18, 2026.

Watch COSM in 60 seconds
Price
$0.35
-7.50% on the day · September 25, 2026
52-week range $0.16 to $1.32
Market cap
$21.8M
Revenue (last 12 months)
$73.7M
+33.8% year on year
Net margin
-33.1%

What Cosmos Health Inc. does

Cosmos Health Inc. is registered with the SEC under industry code SIC 5122 (Wholesale-Drugs, Proprietaries & Druggists' Sundries). Its shares trade on NASDAQ under the ticker COSM.

Revenue and profit by year

Revenue
FY18: $37.1M $37.1M FY18FY19: $39.7M $39.7M FY19FY20: $55.4M $55.4M FY20FY21: $56.2M $56.2M FY21FY22: $50.3M $50.3M FY22FY23: $53.4M $53.4M FY23FY24: $54.4M $54.4M FY24FY25: $65.3M $65.3M FY25
Net income
FY18: -$9.1M -$9.1M FY18FY19: -$3.3M -$3.3M FY19FY20: $820.8K $820.8K FY20FY21: -$8M -$8M FY21FY22: -$13.8M -$13.8M FY22FY23: -$18.5M -$18.5M FY23FY24: -$16.2M -$16.2M FY24FY25: -$19.1M -$19.1M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$65.3M-$16.7M-$19.1M-$0.63-$8.5M
2024$54.4M-$15.5M-$16.2M-$1.17-$8.1M
2023$53.4M-$21.8M-$18.5M-$2.15-$16.9M
2022$50.3M-$7.5M-$13.8M-$33.16-$14.9M
2021$56.2M-$4.5M-$8M-$23.74-$7.7M
2020$55.4M$2.7M$820.8K$1.50-$11.6M

Full financial statements: income, balance sheet and cash flow

Next report expected around November 18, 2026.

Estimated from its filing rhythm: about 90 days after its last report of August 20, 2026, its usual gap. Not a date the company has announced. See the report calendar

Where COSM ranks in Health care

Revenue$65.3M
#353 of 646 in Health care · Bottom 45%
Revenue growth+19.9%
#169 of 474 in Health care · Top 36%
Net margin-29.3%
#313 of 485 in Health care · Bottom 36%
Free cash flow margin-13.0%
#269 of 440 in Health care · Bottom 39%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Cosmos Health Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. August 20, 2026
  2. August 18, 2026
    Quarterly report 10-Q · period to June 30, 2026Revenue rose 29% to $19M versus the same quarter last year; diluted EPS -$0.10 versus -$0.10.
  3. August 14, 2026
  4. July 22, 2026
  5. July 17, 2026
  6. July 16, 2026
  7. July 6, 2026
  8. June 8, 2026
  9. June 5, 2026
  10. June 5, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on July 31, 2026. Insider transactions on SEC

Insider trades

What the people running Cosmos Health Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

Insiders bought $210K worth of shares on the open market in the last 90 days and sold none.

Bought (open market)
$210K
last 90 days
Sold
$0
last 90 days
Net bought
1,116,109
$210K
DateInsiderWhatSharesPriceValueFiling
July 30, 2026 Siokas GrigoriosChief Executive Officer, Director, 10% owner Bought 349,825 $0.20 $70K Form 4
July 29, 2026 Siokas GrigoriosChief Executive Officer, Director, 10% owner Bought 766,284 $0.18 $140K Form 4
July 29, 2026 Terzis GeorgiosChief Financial Officer Received as pay 328,407 $0.18 $60K Form 4
June 16, 2026 Terzis GeorgiosChief Financial Officer Bought 168,135 $0.25 $42K Form 4
June 11, 2026 Siokas GrigoriosChief Executive Officer, Director, 10% owner Bought 218,447 $0.21 $45K Form 4
June 10, 2026 Siokas GrigoriosChief Executive Officer, Director, 10% owner Bought 701,447 $0.23 $160K Form 4
May 19, 2026 Aslidis AnastasiosDirector Received as pay 40,000 $0.28 $11.3K Form 4
May 19, 2026 Demetriades Demetrios G.Secretary, Director Received as pay 20,000 $0.28 $5.7K Form 4
May 19, 2026 Hoidas John JamesDirector Received as pay 20,000 $0.28 $5.7K Form 4
May 19, 2026 Karkantzos Theodoros ChristosDirector Received as pay 20,000 $0.28 $5.7K Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns COSM

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Bovopoulos Andreas13G, passive 7.2% 4,324,197 June 5, 2026

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

6 insiders reported holding 17,401,722 shares in total, about $6.1M at the last price.

HolderSharesAs of
Siokas GrigoriosChief Executive Officer, Director, 10% owner 14,597,917 July 30, 2026
Terzis GeorgiosChief Financial Officer 2,563,805 July 29, 2026
Aslidis AnastasiosDirector 100,000 May 19, 2026
Demetriades Demetrios G.Secretary, Director 55,000 May 19, 2026
Hoidas John JamesDirector 50,000 May 19, 2026
Karkantzos Theodoros ChristosDirector 35,000 May 19, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about COSM

What does Cosmos Health Inc. do?

Cosmos Health Inc. is registered with the SEC under industry code SIC 5122 (Wholesale-Drugs, Proprietaries & Druggists' Sundries). Its shares trade on NASDAQ under the ticker COSM.

Is Cosmos Health Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $24.4M on revenue of $73.7M.

How much revenue does Cosmos Health Inc. make?

Over the twelve months to June 30, 2026 Cosmos Health Inc. reported revenue of $73.7M. That is 33.8% more than a year earlier.

When did Cosmos Health Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 18, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the quarterly results from August 20, 2026.

Similar companies

Compare COSM with

Compare COSM with any company

Follow COSM

Get an email when Cosmos Health Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow COSM: get an email when it files

Where the numbers come from

Financial figures are the values Cosmos Health Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.